生物活性 | |||
---|---|---|---|
描述 | VEGFR-3 is a fms-like tyrosine kinase receptor whose expression is limited almost exclusively to lymphatic endothelium in the adult. VEGFR-3 plays an important role in regulating lymphangiogenesis. MAZ51 is a selective inhibitor of VEGFR-3 tyrosine kinase which inhibits VEGF-C-induced activation of VEGFR-3 without blocking VEGF-C-mediated stimulation of VEGFR2[1]. MAZ51 (2.5-10 μM; 24 h) blocked proliferation and induced apoptosis in a wide variety of tumor cells (MT450, 1AS, ASM, G, AT6.1, MTLN3, MTLY, NM-081 cells). In Wistar Furth rats bearing MT450 cells, MAZ51 (8 mg/kg; i.p.; daily for 15 days) significantly suppressed the growth of MT450 tumors[2]. |
实验方案 | |||
---|---|---|---|
1mg | 5mg | 10mg | |
1 mM 5 mM 10 mM |
3.18mL 0.64mL 0.32mL |
15.90mL 3.18mL 1.59mL |
31.81mL 6.36mL 3.18mL |
参考文献 |
---|